Search Results - "Westholder, James"

Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literature by Rivers, Zachary T, Oostra, Drew R, Westholder, James S, Vercellotti, Gregory M

“…Background Romidepsin is a novel histone deacetylase inhibitor that is approved for the treatment of cutaneous and peripheral T-cell lymphoma in patients who…”
Get full text

Rifampin–sirolimus–voriconazole interaction in a hematopoietic cell transplant recipient by Wasko, Justin A, Westholder, James S, Jacobson, Pamala A

“…Purpose Patients undergoing hematopoietic cell transplantation are treated with multiple medications, potentially complicated by drug–drug interactions. Drug…”
Get full text

Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis by Bajwa, Amneet K, Zhao, Qiuhong, Geer, Marcus Johannes, Mian, Agrima, Lin, Chenyu, Frame, David, Westholder, James, Tossey, Justin, Ghosh, Monalisa, Galal, Ahmed, Ahmed, Nausheen, Maakaron, Joseph E., Denlinger, Nathan, de Lima, Marcos, Epperla, Narendranath, Caimi, Paolo F., Voorhees, Timothy

“…Background: Chimeric Antigen Receptor T-Cell therapies (CAR-T) are effective in a variety of hematologic (hem) malignancies; however, adverse events including…”
Get full text

Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities – a Multicenter Retrospective Analysis by Bajwa, Amneet, Zhao, Qiuhong, Geer, Marcus J., Mian, Agrima, Lin, Chenyu, Frame, David, Westholder, James, Tossey, Dr. Justin, Ghosh, Monalisa, Galal, Ahmed, Ahmed, Nausheen, Maakaron, Joseph E., Denlinger, Nathan, de Lima, Marcos, Epperla, Narendranath, Caimi, Paolo, Voorhees, Timothy

“…Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) can affect a significant number of patients (pts) receiving…”
Get full text

Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Related CRS and ICANS - A Multicenter Retrospective Analysis by Bajwa, Amneet, Zhao, Qiuhong, Geer, Marcus J, Lin, Chenyu, Westholder, James, Maakaron, Joeseph, Ghosh, Monalisa, Frame, David G, Galal, Ahmed, Tossey, Justin, Ahmed, Nausheen, Bezerra, Evandro D, Denlinger, Nathan, de Lima, Marcos J, Epperla, Narendranath, Caimi, Paolo F, Voorhees, Timothy J

“…Chimeric Antigen Receptor T-Cell therapies (CAR-T) are effective in many hematologic malignancies; however, adverse events including cytokine release syndrome…”
Get full text